Post-transplantation anti-HLA antibodies: which relevance?;Intérêt du monitoring du rejet aigu médié par anticorps post-transplantation ?

Nephrologie et Therapeutique

Volumn 4, Issue SUPPL.1, 2008, Pages

  Glotz, D ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Graft rejection; Humoral immunity; Immunologic tests; Transplantation

Indexed keywords

COMPLEMENT COMPONENT C4D; HLA ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT ANTIGEN; RITUXIMAB;

ACUTE GRAFT REJECTION; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; PLASMAPHERESIS; PROGNOSIS; SPLENECTOMY; TRANSPLANTATION;

ACUTE DISEASE; ANTIBODIES; ANTIBODY FORMATION; GRAFT REJECTION; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION;

EID: 48849114061     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1769-7255(08)73645-9     Document Type: Article

References (15)

1. Taylor C.J., Chapman J.R., Ting A., and Morris P.J. Characterization of lymphocytotoxic antibodies causing a positive cross-match in renal transplantation. Relationship to primary and regraft outcome. Transplantation 48 (1989) 953-958
2. Barr ml., Cohen D.J., Benvenisty A.I., Hardy M., Reemtsma K., Rose E.A., et al. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts. Transplant Proc 25 (1993) 262-264
3. Halloran P.F., Schlaut J., Solez K., and Srinivasa N.S. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 53 (1992) 550-555
4. Poggio E.D., Clemente M., Riley J., Roddy M., Greenspan N.S., Dejelo C., et al. Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy. J Am Soc Nephrol 15 (2004) 1952-1960
5. Trpkov K., Campbell P., Pazderka F., Cockfield S., Solez K., and Halloran P.F. Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema. Transplantation 61 (1996) 1586-1592
6. Terasaki P.I. Humoral theory of transplantation. Am J Transplant 3 (2003) 665-673
7. Lee P.C., Terasaki P.I., Takemoto S.K., Lee P.H., Hung C.J., Chen Y.L., et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 74 (2002) 1192-1194
8. Terasaki P.I., and Ozawa M. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant 4 (2004) 438-443
9. Mizutani K., Terasaki P., Rosen A., Esquenazi V., Miller J., Shih R.N., et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 5 9 (2005) 2265-2272
10. Terasaki P.I., Ozawa M., and Castro R. Four-year Follow-up of a Prospective Trial of HLA and MICA Antibodies on Kidney Graft Survival. American Journal of Transplantation 7 (2007) 408-415
11. Mizutani K., Terasaki P., Hamdani E., Esquenazi V., Rosen A., Miller J., et al. The Importance of Anti-HLA-Specific Antibody Strength in Monitoring Kidney Transplant Patients. Am J Transplant 7 (2007) 1027-1031
12. Ozawa M., Terasaki P.I., Lee J.H., Castro R., Alberu J., Alonso C., et al. 14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project. Tissue Antigens 69 1 (2007) 174-179
13. Luke P.P., Scantlebury V.P., Jordan ml., Vivas C.A., Hakala T.R., Jain A., et al. Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients. Transplantation 72 (2001) 419-422
14. Rocha P.N., Butterly D.W., Greenberg A., Reddan D.N., Tuttle-Newhall J., Collins B.H., et al. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation 75 (2003) 1490-1495
15. Faguer S., Kamar N., Guilbeaud-Frugier C., Fort M., Modesto A., Mari A., et al. Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation 8 (2007) 1277-1280